Возраст домена | 18 лет |
Дата окончания | Истек срок регистрации |
PR | 2 |
ИКС | |
Страниц в Google | 557 |
Страниц в Яндексе | 364 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 8088678 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pfizer Plus - Connected. Active. Involved.
n/a
n/a
UTF-8
30.76 КБ
475
3 384 симв.
2 831 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
pfizer.com | 264 | 7 |
0 | 34888 | 14501 | |
pfizerhelpfulanswers.com | 45 | 5 |
0 | Нет данных | Нет данных | |
wikipedia.org | 39 | 9 |
0 | 5 | 6 | |
cafepharma.com | 33 | 5 |
0 | 173271 | 41486 | |
pharmalot.com | 31 | 6 |
10 | 6027354 | Нет данных | |
pfizercareers.com | 29 | 6 |
0 | 4704236 | Нет данных | |
youtube.com | 28 | 9 |
0 | 2 | 2 | |
linkedin.com | 27 | 9 |
0 | 25 | 10 | |
pfizerpro.com | 27 | 6 |
10 | 500126 | 147066 | |
cbsnews.com | 26 | 9 |
0 | 1163 | 262 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 20 Ноября 2016 ) | |
Количество ссылок на сайт | 29 |
Количество доменов, которые ссылаются на сайт | 25 |
Количество найденных анкоров | 16 |
Исходящие (внешние) ссылки домена | 213 |
Количество доменов, на которые ссылается сайт | 63 |
Количество исходящих анкоров | 73 |
Внешние ссылки главной страницы ( 12 ) | |
netbenefits.com | Pfizer Benefits |
pfizer.com/press-release-detail-view | - |
pfizer.com/news/press-release/press-release-detail/theravanc... | Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inh... |
pfizer.com/news/press-release/press-release-detail/u_s_fda_a... | U.S. FDA Accepts and Grants Priority Review to sNDA for BRAFTOVI® (encorafenib) in Combination with ERBITUX® (cetuximab) (BRAFTO... |
pfizer.com/news/press-release/press-release-detail/pfizer_an... | Pfizer and Mylan Announce Two Future Viatris Board Members |
pfizer.com/news/press-release/press-release-detail/pfizer_in... | Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts |
pfizer.com/news/press-release/press-release-detail/xtandi_en... | XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer |
pfizer.com/news/press-release/press-release-detail/pfizer_de... | Pfizer Declares First-Quarter 2020 Dividend and Announces Upcoming Investor Day to Highlight Strength of Innovative R&D Pipeline |
pfizer.com/news/press-release/press-release-detail/pfizer_re... | Pfizer Receives Positive CHMP Opinion for VYNDAQEL® for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fa... |
pfizer.com/news/press-release/press-release-detail/fda_appro... | FDA Approves XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis |
facebook.com/Pfizer | <img> |
twitter.com/pfizer | <img> |
Внутренние ссылки главной страницы ( 22 ) | |
/ | <img> |
/kb/contact.aspx | Contacts |
/home.aspx | <img> |
/si/home.aspx | Stay Informed |
/gi/home.aspx | Get Involved |
/bh/home.aspx | Be Healthy |
/kb/home.aspx | Know Your Benefits |
/cc/home.aspx | Member Sign-In |
/bh/focus/december2019.aspx | Read more |
/si/article_healthy_holiday_season.aspx | Read more |
/si/article_holiday_spirit_12_days_doing.aspx | Read more |
/si/article_5_holiday_traditions_around_the_world.aspx | Read more |
/bh/get_healthy.aspx | Read more |
/kb/pfizer_benefits.aspx | Have a Question About Your Benefits? Visit the Pfizer Benefits Center for answers! |
/kb/rx_coverage.aspx | Pfizer Zero CostDrug List An updated Pfizer Zero Copay Drug List / Greenstone Generic Drug List is now available. (October 2018) |
/kb/preventive_care.aspx | Preventive Care: What You Should Know Preventive care services include lab tests, screenings, exams, and vaccines. These service... |
/si/get-old.aspx | Get Inspired & Learn More |
/cc/member_benefits.aspx | Sign Up Now |
/general/privacy.jsp | <img> |
/contact.aspx | Contact Us |
/pfizer/mn_terms.jsp | Terms of Use |
/pfizer/privacy/mn_privacy_truste.jsp | Privacy Statement |
Domain Name: PFIZERPLUS.COM
Registry Domain ID: 354585441_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2018-01-21T10:05:50Z
Creation Date: 2006-02-22T17:39:16Z
Registry Expiry Date: 2020-02-22T17:39:16Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.P15.DYNECT.NET
Name Server: NS2.P15.DYNECT.NET
Name Server: NS3.P15.DYNECT.NET
Name Server: NS4.P15.DYNECT.NET
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-11-27T20:57:39Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
США - Нью-Йорк - 170.20.0.18
США - Нью-Йорк - 170.20.0.19
CBS
CBS Corporation
HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 31499
Content-Type: text/html; charset=utf-8
Server: Microsoft-IIS/7.5
X-AspNet-Version: 4.0.30319
Set-Cookie: ASP.NET_SessionId=rzyyylbnkx2s310lbz2x5vk4; path=/; HttpOnly
X-Powered-By: ASP.NET
X-Frame-Options: DENY
Date: Sun, 29 Dec 2019 05:04:14 GMT
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"